Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)

International Journal of Antimicrobial Agents

Volumn 27, Issue 6, 2006, Pages 468-475

  Zhanel, George G ^a,b   Hisanaga, Tamiko L ^a   Laing, Nancy M ^a   DeCorby, Melanie R ^a   Nichol, Kim A ^b   Weshnoweski, Barb ^b   Johnson, Jack ^c   Noreddin, Ayman ^d   Low, Don E ^e   Karlowsky, James A ^a,b   Hoban, Daryl J ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c Division of Microbiology   (United States)

^d UNIVERSITY OF MINNESOTA DULUTH   (United States)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Antibiotic resistance; Escherichia coli; Urinary

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; NITROFURANTOIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DEMOGRAPHY; ESCHERICHIA COLI; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; OUTPATIENT; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTPATIENTS; PHENOTYPE; URINARY TRACT INFECTIONS;

EID: 33747325623     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.02.009     Document Type: Article

References (26)

1. Nicolle L.E. Urinary tract infection: traditional pharmacologic therapies. Am J Med 113 Suppl. 1A (2002) 35-44
2. Ronald A.R., Nicolle L.E., Stamm E., et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents 4 (2001) 343-348
3. Hooton T.M., Besser R., Foxman B., Fritsche T.R., and Nicolle L.E. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 39 (2004) 75-80
4. Nicolle L.E. Epidemiology of urinary tract infection. Clin Microbiol Newsl 24 (2001) 135-140
5. Gupta K., Hooton T.M., Wobbe C.L., and Stamm W.E. The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents 11 (1999) 305-308
6. Gupta K., and Stamm W.E. Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int J Antimicrob Agents 19 (2002) 554-556
7. Hooton T.M. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection. Int J Antimicrob Agents 2 (2003) 65-72
8. Karlowsky J.A., Jones M.E., Thornsberry C., Critchley I., Kelly L.J., and Sahm D.F. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents 18 (2001) 121-127
9. Karlowsky J.A., Kelly L.J., Thornsberry C., Jones M.E., and Sahm D.F. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 46 (2002) 2540-2545
10. Karlowsky J.A., Thornsberry C., Jones M.E., and Sahm D.F. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis 36 (2003) 183-187
11. Sahm D.F., Thornsberry C., Mayfield D.C., Jones M.E., and Karlowsky J.A. Multi-drug resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 45 (2001) 1402-1406
12. Zhanel G.G., Karlowsky J.A., Harding G.K.M., et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. Antimicrob Agents Chemother 44 (2000) 1089-1092
13. Zhanel G.G., Hisanaga T.L., Laing N.M., et al., the NAUTICA Group. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 26 (2005) 380-388
14. Huang E.S., and Stafford R.S. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 162 (2002) 41-47
15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 6th ed. M7-A6 Vol. 23, No. 2 (2003), NCCLS, Wayne, PA
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement (M100-S15) Vol. 25, No. 1 (2005), CLSI, Wayne, PA
17. Raz R., Chazan B., Kennes Y., et al., Israeli Urinary Tract Infection Group. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 34 (2002) 1165-1169
18. Brown P.D., Freeman A., and Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 34 (2002) 1061-1066
19. Carrie A.G., Metge C.J., Collins D.M., Harding G.K.M., and Zhanel G.G. Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the treatment of community-acquired acute pyelonephritis in women. J Antimicrob Chemother 53 (2004) 512-517
20. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., and Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29 (1999) 745-758
21. Killgore K.M., March K.L., and Guglielmo B.J. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. Ann Pharmacother 38 (2004) 1148-1152
22. Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 168 (2002) 1720-1722
23. Bolon M.K., Wright S.B., Gold H.S., and Carmeli Y. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported. Antimicrob Agents Chemother 48 (2004) 1934-1940
24. Gupta K., Hooton T.M., and Stamm W.E. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. J Antimicrob Chemother 56 (2005) 243-246
25. Hooton T.M. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection. Int J Antimicrob Agents 22 Suppl. 2 (2003) 65-72
26. Talan D.A., Stamm W.E., Hooton T.M., et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 283 (2000) 1583-1590